Amwell®, a prominent provider of digital care solutions, has announced the integration of Vida Health’s virtual cardiometabolic care services into its clinical programs portfolio. According to the company, the initiative, branded as “Amwell Cardiometabolic Care Powered by Vida,” will provide access to comprehensive obesity and diabetes care for members through Amwell’s platform.
This partnership targets a significant public health challenge. More than 40% of American adults face obesity, a condition linked to increased risks of diabetes, heart disease, and cancer. Together, obesity and diabetes account for over $500 billion in annual U.S. healthcare costs. Through this collaboration, Amwell aims to deliver tailored, evidence-based care to address these widespread health issues.
A Unified Approach to Cardiometabolic Health
The new program will be available to Amwell’s extensive network of health plan and employer clients. It includes access to Vida Health’s suite of cardiometabolic care services, encompassing obesity management, diabetes prevention and treatment, and behavioral health support. According to Amwell, the services integrate social determinants of health, considering factors like food security, financial barriers, cultural norms, and beliefs to customize care plans.
Vida Health’s CEO, Joe Murad, emphasized the partnership’s potential for improving care accessibility and outcomes. “By leveraging our complementary capabilities, we’re making it easier than ever to provide members with personalized, high-touch care,” Murad stated. “Together, we’re working to reduce member friction, improve health outcomes at scale, and reduce costs.”
Incorporating Advanced Therapies
Vida Health’s offerings include the prescription of GLP-1 receptor agonists and other anti-obesity medications, alongside lifestyle interventions such as Medical Nutrition Therapy. These treatments are delivered under a value-based, outcomes-driven care model. The company asserts that this approach ensures measurable results and accountability, though specific outcomes were not detailed in the announcement.
Amwell CEO Ido Schoenberg highlighted the benefits of integrating Vida’s programs. “With this partnership, our health plan clients can offer members a single entry point to the clinical and behavioral health support they need for obesity care and related illnesses,” Schoenberg said. He noted that the programs are adaptable to individual patient needs, providing a cost-effective and evidence-based method for managing weight-related health challenges.
Expanding Amwell’s Clinical Portfolio
Amwell’s clinical programs portfolio includes a range of virtual and digital care solutions from third-party partners, targeting diverse health conditions. According to the company, this portfolio is designed to offer a unified entry point for members, simplifying access to various care programs. Amwell positions its platform as a tool for achieving whole-person care, emphasizing improved health outcomes and operational efficiencies for health plans and employers.
The inclusion of Vida Health aligns with Amwell’s strategy of broadening its offerings to address chronic and complex health conditions. By integrating services that focus on obesity and related metabolic disorders, Amwell claims it is advancing its mission to provide comprehensive, coordinated care.
About the Companies
Vida Health Vida Health specializes in virtual obesity and metabolic care, utilizing a combination of human expertise and AI-powered insights. The company’s holistic approach aims to deliver sustainable health outcomes, with services offered nationwide in English and Spanish. Vida operates on a value-based pricing model, prioritizing results over service volume.
Amwell Amwell provides a hybrid care delivery platform connecting providers, payers, and patients. With nearly 20 years of experience, Amwell supports over 50 health plans and serves more than 100 million covered lives. The company’s platform addresses a spectrum of digital health needs, from urgent care to chronic condition management.
Looking Ahead
While the collaboration between Amwell and Vida Health promises expanded access to cardiometabolic care, its real-world impact remains to be seen. By integrating advanced therapies and addressing social determinants of health, the program seeks to tackle some of the most pressing healthcare challenges in the United States. As the initiative unfolds, its effectiveness in improving outcomes and reducing costs will be closely watched by industry stakeholders.
